Latest Retinoids Stories
HAYWARD, Calif., Feb. 23 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced it has entered into a definitive agreement to acquire privately-held Aesthera Corporation, which is based in Pleasanton, California.
CINCINNATI, Feb. 15 /PRNewswire/ -- Today, the British Journal of Dermatology, one of the world's leading dermatology journals, published a head-to-head anti-aging clinical trial comparing an off the shelf brand to the leading prescription wrinkle regimen, 0.02 percent tretinoin.
NEW YORK, Sept. 9 /PRNewswire/ -- In 2008, the global anti-aging skincare market approached $15 billion(1), with 32 percent of U.S.
PLEASANTON, Calif., July 15 /PRNewswire/ -- Roche Holding AG, the world's biggest maker of cancer drugs, recently announced the withdrawal of its Accutane acne medicine from the US Market.
TRENTON, N.J., June 26 /PRNewswire/ -- Marcus Rayner, executive director of the New Jersey Lawsuit Reform Alliance, a statewide, bipartisan group of individuals, businesses and organizations dedicated to improving the state's civil justice system and advocating for legal reform in the legislature and in the courts, today issued the following statement in reaction to Roche's announcement that the company will immediately discontinue Accutane(R), a treatment for severe acne: "Thanks to an...
Roche Holding AG announced on Friday that it is no longer selling its acne drug Accutane amid slowing sales due to the move towards generic alternatives.
Company brings the latest in Italian skin care to the U.S. TURIN, Italy, March 17 /PRNewswire/ -- Direct from Italy, Perlabella PureDose Pearls bring the latest in anti-aging skin care technology to America.
SAN DIEGO, March 6 /PRNewswire/ -- AndroScience Corporation (ASC(TM)), a developmental stage pharmaceutical company announced results of a Phase 2a dose-ranging study of their lead clinical compound for the treatment of acne.
Expanded Dermatology Division of Valeant Pharmaceuticals Introduces Fixed Combination Acne Treatment Designed to Increase Patient Satisfaction and Use SAN FRANCISCO, March 6 /PRNewswire-FirstCall/ -- Coria Laboratories, the newly expanded dermatology division of Valeant Pharmaceuticals International (NYSE: VRX), announced today the commercial launch of Acanya(TM) Gel (clindamycin phosphate 1.2% and benzoyl peroxide 2.5%) indicated for the once-daily treatment of acne vulgaris in patients 12...
FORT WORTH, Texas, Feb.